Monoclonal Antibody
Total Trials
1
As Lead Sponsor
0
As Collaborator
NCT01689870
Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma
Phase: Phase 1/2
Role: Collaborator
Start: Mar 31, 2014
Completion: Aug 31, 2014
Loading map...